Clinical Trial Update: Feasibility Study on the Use of PET-MRI / 68Ga-PSMA Imaging for HIFU-focal Treatment in the Event of Recurrent Prostate Cancer After Radiotherapy - PSMA Study [NA]

View source ↗

Summary

The trial completed a feasibility study evaluating PET-MRI with 68Ga-PSMA imaging to guide HIFU focal treatment for recurrent prostate cancer after radiotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA imaging tracer (Gallium-68 PSMA ligand)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Prostate Cancer | NA | Status: COMPLETED